These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11532900)

  • 1. Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis.
    McDermott DH; Halcox JP; Schenke WH; Waclawiw MA; Merrell MN; Epstein N; Quyyumi AA; Murphy PM
    Circ Res; 2001 Aug; 89(5):401-7. PubMed ID: 11532900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
    Niessner A; Marculescu R; Haschemi A; Endler G; Zorn G; Weyand CM; Maurer G; Mannhalter C; Wojta J; Wagner O; Huber K
    Thromb Haemost; 2005 May; 93(5):949-54. PubMed ID: 15886814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of V249I and T280M polymorphisms in the chemokine receptor CX3CR1 gene with early onset of coronary artery disease among North Indians.
    Singh N; Rai H; Sinha N; Kumar S; Pandey CM; Agrawal S
    Genet Test Mol Biomarkers; 2012 Jul; 16(7):756-60. PubMed ID: 22731642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of polymorphisms in the chemokine receptor CX3CR1 gene with coronary artery disease.
    Matzhold EM; Trummer O; Grünbacher G; Zulus B; Boehm BO; März W; Renner W
    Cytokine; 2009 Sep; 47(3):224-7. PubMed ID: 19628406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors.
    Nassar BA; Nanji AA; Ransom TP; Rockwood K; Kirkland SA; Macpherson K; Connelly PW; Johnstone DE; O'Neill BJ; Bata IR; Andreou P; Title LM
    Scand J Clin Lab Invest; 2008; 68(4):286-91. PubMed ID: 18609106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine receptor CX3CR-1 and fractalkine: new factors in the atherosclerosis drama?
    Alexander RW
    Circ Res; 2001 Aug; 89(5):376-7. PubMed ID: 11532896
    [No Abstract]   [Full Text] [Related]  

  • 7. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
    Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease.
    Moatti D; Faure S; Fumeron F; Amara Mel-W; Seknadji P; McDermott DH; Debré P; Aumont MC; Murphy PM; de Prost D; Combadière C
    Blood; 2001 Apr; 97(7):1925-8. PubMed ID: 11264153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of coronary vascular endothelial dysfunction.
    Halcox JP; Schenke WH; Zalos G; Mincemoyer R; Prasad A; Waclawiw MA; Nour KR; Quyyumi AA
    Circulation; 2002 Aug; 106(6):653-8. PubMed ID: 12163423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine CX3CL1 and its receptor CX3CR1 are associated with human atherosclerotic lesion volnerability.
    Zhang X; Feng X; Cai W; Liu T; Liang Z; Sun Y; Yan C; Han Y
    Thromb Res; 2015 Jun; 135(6):1147-53. PubMed ID: 25845619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease.
    Apostolakis S; Baritaki S; Kochiadakis GE; Igoumenidis NE; Panutsopulos D; Spandidos DA
    Thromb Res; 2007; 119(1):63-71. PubMed ID: 16480760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internal carotid artery occlusive disease and polymorphisms of fractalkine receptor CX3CR1: a genetic risk factor.
    Ghilardi G; Biondi ML; Turri O; Guagnellini E; Scorza R
    Stroke; 2004 Jun; 35(6):1276-9. PubMed ID: 15118174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease Phenotype.
    Brand S; Hofbauer K; Dambacher J; Schnitzler F; Staudinger T; Pfennig S; Seiderer J; Tillack C; Konrad A; Göke B; Ochsenkühn T; Lohse P
    Am J Gastroenterol; 2006 Jan; 101(1):99-106. PubMed ID: 16405540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between the functional CX3CR1 polymorphism V249I and hepatocellular carcinoma.
    Mühlbauer M; Ringel S; Hartmann A; Lallinger G; Weiss TS; Gäbele E; Wünsch PH; Schölmerich J; Hellerbrand C
    Oncol Rep; 2005 May; 13(5):957-63. PubMed ID: 15809764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of fractalkine receptor CX3CR1 gene in patients with symptomatic and asymptomatic carotid artery stenosis.
    Kimouli M; Miyakis S; Georgakopoulos P; Neofytou E; Achimastos AD; Spandidos DA
    J Atheroscler Thromb; 2009 Oct; 16(5):604-10. PubMed ID: 19755791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common CX3CR1 alleles are associated with a reduced risk of headaches.
    Combadière C; Godin O; Vidal C; Cangialosi A; Proust C; Tzourio C
    Headache; 2008 Jul; 48(7):1061-6. PubMed ID: 18194290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of the C242T p22phox gene polymorphism to angiographic coronary artery disease and endothelial function.
    Li A; Prasad A; Mincemoyer R; Satorius C; Epstein N; Finkel T; Quyyumi AA
    Am J Med Genet; 1999 Sep; 86(1):57-61. PubMed ID: 10440830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
    Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
    Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two polymorphisms in the Fractalkine receptor CX3CR1 gene influence the development of atherosclerosis: a meta-analysis.
    Wu J; Yin RX; Lin QZ; Guo T; Shi GY; Sun JQ; Shen SW; Li Q
    Dis Markers; 2014; 2014():913678. PubMed ID: 25221380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis.
    Bagci B; Bagci G; Huzmeli C; Sezgin I; Ozdemir O
    Int Urol Nephrol; 2016 Jul; 48(7):1163-70. PubMed ID: 27118566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.